These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 5701829

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [BCG vaccination and chemoprophylaxis of tuberculosis. Current status. Indications].
    De March Ayuela P.
    Med Clin (Barc); 1965 Aug; 45(2):81-94. PubMed ID: 5324020
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. [Relations between vaccination and chemoprophylaxis with INH].
    Lucchesi M, Spina G.
    Lotta Tuberc; 1965 Aug; 35(11):1049-54. PubMed ID: 5223589
    [No Abstract] [Full Text] [Related]

  • 25. [Comparative characteristics of the activity of proteolytic enzymes and their inhibitors in the lung tissue of guinea pigs during development of generalized and destructive tuberculosis].
    Zhukova NL, Gedymin LE, Golyshevskaia VI.
    Vopr Med Khim; 1986 Aug; 32(5):80-4. PubMed ID: 3535249
    [Abstract] [Full Text] [Related]

  • 26. [Studies on tubercle bacilli and their contaminant bacteria in the sputum of pulmonary tuberculosis after chemotherapy ].
    Sakai I.
    Hokkaido Igaku Zasshi; 1982 Mar; 57(2):211-6. PubMed ID: 6811390
    [Abstract] [Full Text] [Related]

  • 27. [The effect of silicon on the tuberculous infection and immune system].
    Shen FZ.
    Zhonghua Jie He He Hu Xi Za Zhi; 1991 Oct; 14(5):292-4, 320. PubMed ID: 1819382
    [Abstract] [Full Text] [Related]

  • 28. [Prevention of tuberculosis: vaccination and chemoprophylaxis].
    Spada S.
    Clin Ter; 1968 Aug 15; 46(3):277-86. PubMed ID: 4918931
    [No Abstract] [Full Text] [Related]

  • 29. [Characteristics of lung ultrastructure and variability mutability , mutation of the causative agent in experimental tuberculosis].
    Dzis' EI, Indutnyĭ ON.
    Probl Tuberk; 1988 Aug 15; (12):42-5. PubMed ID: 3072562
    [No Abstract] [Full Text] [Related]

  • 30. [Characteristics of morphological changes in the lungs of guinea pigs after administration of ultra-small forms of Mycobacteria obtained from patients with tuberculosis].
    Khomenko AG, El'shanskaia MP, Akhunov ShB, Golyshevskaia VI.
    Probl Tuberk; 1986 Aug 15; (6):46-50. PubMed ID: 3092208
    [No Abstract] [Full Text] [Related]

  • 31. Tuberculous morbidity in Swiss albino mice immunized with BCG.
    Costello R, Slats S.
    J Hyg (Lond); 1970 Dec 15; 68(4):589-99. PubMed ID: 4992576
    [Abstract] [Full Text] [Related]

  • 32. [Pulmonary dusting and experimental infection. VII. The effect of B.C.G. vaccination on the lungs of guinea pigs dusted with charcoal].
    Gaudier B, Martin JC, Le Bouffant L, Tacquet A, Ballester L.
    Ann Inst Pasteur Lille; 1970 Dec 15; 21():101-13. PubMed ID: 5526027
    [No Abstract] [Full Text] [Related]

  • 33. [Effectiveness of the rapid intravenous administration of rifampicin and isoniazid and of the intramuscular administration of streptomycin in disseminated destructive pulmonary tuberculosis in dogs].
    Bondarev IM, Ivanov VL, Novoselova VP, Kovaleva LA, Shtegel'man LA.
    Antibiotiki; 1984 Jun 15; 29(6):430-4. PubMed ID: 6476805
    [Abstract] [Full Text] [Related]

  • 34. [Antitubercular chemoprophylaxis after 20 years of its world-wide application].
    Zorini AO.
    Minerva Med; 1979 Jan 14; 70(2):89-96. PubMed ID: 372851
    [Abstract] [Full Text] [Related]

  • 35. Lymphadenitis as a major element of disease in the guinea pig model of tuberculosis.
    Basaraba RJ, Dailey DD, McFarland CT, Shanley CA, Smith EE, McMurray DN, Orme IM.
    Tuberculosis (Edinb); 2006 Sep 14; 86(5):386-94. PubMed ID: 16473044
    [Abstract] [Full Text] [Related]

  • 36. [Chemoprophylaxis of tuberculosis with isoniazid. (Biological problems and clinical problems)].
    Zorini AO.
    J Med (Oporto); 1966 Jan 15; 59(199):143-55. PubMed ID: 5216691
    [No Abstract] [Full Text] [Related]

  • 37. BCG versus isoniazid in the prevention of tuberculosis.
    Sifontes JE.
    Bol Asoc Med P R; 1980 Mar 15; 72(3):111-6. PubMed ID: 6930275
    [No Abstract] [Full Text] [Related]

  • 38. [Treatment of malignant tumors by an extract from tubercle bacilli (tuberculosis vaccine].
    Maruyama C.
    Nihon Ika Daigaku Zasshi; 1971 Oct 15; 38(5):267-76. PubMed ID: 5144142
    [No Abstract] [Full Text] [Related]

  • 39. [Examining fibrotic process in lung during treatment of chronic murine tuberculosis with lysosomotropic drug isonaizid].
    Filimonov PN, Shkurupiĭ VA, Kurunov IuN, Pupyshev AB, Panasenko SG.
    Probl Tuberk; 1999 Oct 15; (1):63-5. PubMed ID: 10199191
    [Abstract] [Full Text] [Related]

  • 40. [Tubazid therapy of cavernous pulmonary tuberculosis in rabbits].
    Bondarev IM, Klebanova AA, Novoselova VP.
    Probl Tuberk; 1969 Oct 15; 47(1):77-83. PubMed ID: 5380215
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.